Seneca Biopharma, Inc. (Nasdaq:SNCA), today announced the agreement by several accredited investors to exercise certain warrants to purchase up to an aggregate of 5,555,554 shares of common stock having an exercise price of $2.70 issued by the company on July 30, 2019,
January 17, 2020
· 4 min read